Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033548 · ClinicalTrials.gov registry record
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
A clinical trial, sponsored by CareDx.
- Terminated
- Registry status
- 246
- Enrollment target
NCT05033548 is a clinical trial that was terminated before completion, run by CareDx. The registered enrollment target is 246 participants.
The verdict
NCT05033548 was terminated before completion, sponsored by CareDx.
- TERMINATED
- Registry status
- 246 participants
- Enrollment target
Study Summary
The primary objective of the study is to assess the impact of AlloCare mHealth remote monitoring on the early post-transplant period in solid organ transplantation.The outcome measure for primary objective is overall reduction in Readmission Rate to hospital in 90 days for all causes. Patients will be assessed across 4 different organ groups (Kidney, Liver, Lung and Heart Transplantation). The secondary objective is to consider the impact of mHealth and app-based monitoring on variables known to impact long term outcomes over the first 12 months post transplantation, as well as impact on quality of life. The outcome measures for secondary objective are: 1. Tacrolimus Variability (Time in Therapeutic Range,) as a surrogate to adherence and compliance 2. BPAR within 3,6, and 12 months 3. Patient satisfaction at 90 days 4. SF-36 change at 90 days 5. HbA1c monitoring (diabetic patients only)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2023-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05033548
The ClinicalTrials.gov registry entry for NCT05033548 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CareDx, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05033548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05033548 about?
NCT05033548 is a clinical study titled "Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient". The primary objective of the study is to assess the impact of AlloCare mHealth remote monitoring on the early post-transplant period in solid organ transplantation.The outcome measure for primary objective is overall reduction in Readmission Rate to hospital in 90 days for all causes. Patients will ...
What is the current status of trial NCT05033548?
This trial is currently terminated. The enrollment target is 246 participants. The study started on 2021-10-26. Estimated completion is 2023-07-31.
Who is sponsoring clinical trial NCT05033548?
This trial is sponsored by CareDx, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.